The Democratic Republic of the Congo is set to receive 70,000 doses of the Ervebo vaccine, which has proven effective in previous Ebola outbreaks, the World Health Organisation (WHO) and its partners said on Thursday.
The WHO said in a statement that while it’s not known whether Ervebo may protect against the Bundibugyo strain of the virus, “early laboratory and animal data suggest it may provide some protection.”